Immunity to the melanoma inhibitor of apoptosis protein (ML-IAP; livin) in patients with malignant melanoma

Therapeutic targeting of melanoma antigens frequently focuses on the melanocyte differentiation or cancer-testis families. Antigen-loss variants can often result, as these antigens are not critical for tumor cell survival. Exploration of functionally relevant targets has been limited. The melanoma i...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhou, Jun, Yuen, Noah K., Zhan, Qian, Velazquez, Elsa F., Murphy, George F., Giobbie-Hurder, Anita, Hodi, F. Stephen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer-Verlag 2011
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3337996/
https://www.ncbi.nlm.nih.gov/pubmed/22033581
http://dx.doi.org/10.1007/s00262-011-1124-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3337996/
https://www.ncbi.nlm.nih.gov/pubmed/22033581
http://dx.doi.org/10.1007/s00262-011-1124-1

Ejemplares similares